Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P P Hung

Showing results (41-50 of 62) with videos related to

Pageof 7
Sort By:
Gene|May 14, 1990
Conservation of essential sequences in the major late promoter and tripartite leader of the simian adenovirus type 30C L Hsiao, K J Woessner, S M Cheng, et al.
Vaccine|April 1, 1995
Isolation and characterization of a highly attenuated respiratory syncytial virus (RSV) vaccine candidate by mutagenesis of the incompletely attenuated RSV A2 ts-1 NG-1 mutant virusK H Hsu, J E Crowe, M D Lubeck, et al.
Vaccine|June 1, 1994
Satisfactorily attenuated and protective mutants derived from a partially attenuated cold-passaged respiratory syncytial virus mutant by introduction of additional attenuating mutations during chemical mutagenesisJ E Crowe, P T Bui, W T London, et al.
Virology|October 1, 1994
Substrate specificity of the NS3 serine proteinase of hepatitis C virus as determined by mutagenesis at the NS3/NS4A junctionS S Leinbach, R A Bhat, S M Xia, et al.
Journal of Virology|February 1, 1988
Distinctive properties of the hepatitis B virus envelope proteinsK L Molnar-Kimber, V Jarocki-Witek, S K Dheer, et al.
Gene|January 28, 1994
Construction and characterization of adenovirus co-expressing hepatitis B virus surface antigen and interleukin-6T Lindley, K P Virk, M Ronchetti-Blume, et al.
Virus Research|June 1, 1985
Sequence of the serotype-specific glycoprotein of the human rotavirus Wa strain and comparison with other human rotavirus serotypesB B Mason, S K Dheer, C L Hsiao, et al.
Circulation|April 1, 1991
Induction of sustained patency after clot-selective coronary thrombolysis with Hybrid-B, a genetically engineered plasminogen activator with a prolonged biological half-lifeC J Weinheimer, H L James, N K Kalyan, et al.
Journal of Medical Virology|November 1, 1991
Effects of purine nucleoside analogues with a cyclobutane ring and erythromycin A oxime derivatives on duck hepatitis B virus replication in vivo and in cell culture and HIV-1 in cell cultureL F Hung, A E Brumbaugh, G Bhatia, et al.
Archives of Virology|January 1, 1988
A new hamster model for adenoviral vaccinationR N Hjorth, G M Bonde, W A Pierzchala, et al.
Pageof 7

Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
Gene|May 14, 1990
Conservation of essential sequences in the major late promoter and tripartite leader of the simian adenovirus type 30C L Hsiao, K J Woessner, S M Cheng, et al.
Vaccine|April 1, 1995
Isolation and characterization of a highly attenuated respiratory syncytial virus (RSV) vaccine candidate by mutagenesis of the incompletely attenuated RSV A2 ts-1 NG-1 mutant virusK H Hsu, J E Crowe, M D Lubeck, et al.
Vaccine|June 1, 1994
Satisfactorily attenuated and protective mutants derived from a partially attenuated cold-passaged respiratory syncytial virus mutant by introduction of additional attenuating mutations during chemical mutagenesisJ E Crowe, P T Bui, W T London, et al.
Virology|October 1, 1994
Substrate specificity of the NS3 serine proteinase of hepatitis C virus as determined by mutagenesis at the NS3/NS4A junctionS S Leinbach, R A Bhat, S M Xia, et al.
Journal of Virology|February 1, 1988
Distinctive properties of the hepatitis B virus envelope proteinsK L Molnar-Kimber, V Jarocki-Witek, S K Dheer, et al.
Gene|January 28, 1994
Construction and characterization of adenovirus co-expressing hepatitis B virus surface antigen and interleukin-6T Lindley, K P Virk, M Ronchetti-Blume, et al.
Virus Research|June 1, 1985
Sequence of the serotype-specific glycoprotein of the human rotavirus Wa strain and comparison with other human rotavirus serotypesB B Mason, S K Dheer, C L Hsiao, et al.
Circulation|April 1, 1991
Induction of sustained patency after clot-selective coronary thrombolysis with Hybrid-B, a genetically engineered plasminogen activator with a prolonged biological half-lifeC J Weinheimer, H L James, N K Kalyan, et al.
Journal of Medical Virology|November 1, 1991
Effects of purine nucleoside analogues with a cyclobutane ring and erythromycin A oxime derivatives on duck hepatitis B virus replication in vivo and in cell culture and HIV-1 in cell cultureL F Hung, A E Brumbaugh, G Bhatia, et al.
Archives of Virology|January 1, 1988
A new hamster model for adenoviral vaccinationR N Hjorth, G M Bonde, W A Pierzchala, et al.
Pageof 7